Pediatrix Medical Group (NYSE:MD) Releases Earnings Results, Beats Expectations By $0.12 EPS

Pediatrix Medical Group (NYSE:MD - Get Free Report) issued its quarterly earnings data on Thursday. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.12, Zacks reports. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The business had revenue of $502.36 million for the quarter, compared to analysts' expectations of $486.22 million.

Pediatrix Medical Group Stock Up 0.6 %

Pediatrix Medical Group stock traded up $0.09 during trading hours on Monday, reaching $15.70. The stock had a trading volume of 591,833 shares, compared to its average volume of 554,201. Pediatrix Medical Group has a 52 week low of $6.62 and a 52 week high of $17.67. The company has a market cap of $1.35 billion, a price-to-earnings ratio of -13.08, a PEG ratio of 1.74 and a beta of 1.57. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42. The business's 50 day moving average price is $13.89 and its 200-day moving average price is $13.01.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on MD. UBS Group boosted their target price on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a "neutral" rating in a report on Friday. Mizuho boosted their price objective on Pediatrix Medical Group from $13.00 to $15.00 and gave the stock a "neutral" rating in a research note on Tuesday, November 19th. Truist Financial raised their price objective on Pediatrix Medical Group from $15.00 to $18.00 and gave the company a "hold" rating in a research note on Friday. Macquarie assumed coverage on Pediatrix Medical Group in a research report on Monday, December 16th. They set an "outperform" rating and a $18.00 target price on the stock. Finally, StockNews.com raised shares of Pediatrix Medical Group from a "hold" rating to a "buy" rating in a research report on Wednesday, January 22nd. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $17.08.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.